Capricor Therapeutics CAPR
NASDAQ CAPR
$10.60 -0.62 (-5.53%)
As of: Nov 12, 2026 · 9:31 AM EST

Capricor Therapeutics (CAPR) Return on Sales [ROS] (2011 - 2025)

Updated

Capricor Therapeutics (CAPR) reported Return on Sales [ROS] of -776.71% for Q3 2025, down 201.47 percentage points from -575.24% a year earlier and down 229.78 percentage points from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Return on Sales [ROS] (2011 - 2025) Analysis & Trends

For FY2024, Capricor Therapeutics posted Return on Sales [ROS] of -190.87%, down 95.24 percentage points from FY2023.

  • Return on Sales [ROS] has a five-year change of +578.65 percentage points (FY2019 to FY2024).
  • By year, Return on Sales [ROS] came in at -95.63% in FY2023 (+1068.30 pp), -1163.93% in FY2022 (+7385.93 pp), -8549.86% in FY2021 (-4137.30 pp) and -4412.56% in FY2020 (-3643.04 pp).
  • The Q3 2025 figure ranks as the lowest quarterly Return on Sales [ROS] since Q4 2022.
  • Year over year, Return on Sales [ROS] has now declined in each of the last six quarters, with an average year-over-year change of -37.35 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q3 2021 (a gain of 17020.88 percentage points); the low point was Q1 2021 (a drop of 11509.82 percentage points).
  • Per Business Quant data, the three quarters before Q3 2025 came in at -546.93% (Q2 2025), -329.33% (Q1 2025) and -68.96% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Capricor Therapeutics 515.69 Mn -516.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -776.71%
Jun 30, 2025 -546.93%
Mar 31, 2025 -329.33%
Dec 31, 2024 -68.96%
Sep 30, 2024 -575.24%
Jun 30, 2024 -291.86%
Mar 31, 2024 -209.21%
Dec 31, 2023 -10.60%
Sep 30, 2023 -110.97%
Jun 30, 2023 -197.76%
Mar 31, 2023 -274.04%
Dec 31, 2022 -840.33%
Sep 30, 2022 -407.00%
Dec 31, 2021 -8,549.86%
Sep 30, 2021 -6,190.16%
Jun 30, 2021 -2,490.75%
Mar 31, 2021 -12,644.77%
Dec 31, 2020 -7,229.02%
Sep 30, 2020 -23,211.04%
Jun 30, 2020 -6,994.72%
API Access

Capricor Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CAPR&period=max&api_key=YOUR_API_KEY